Author/Authors :
Hosseini, Behnam Anesthesiology Research Center - Shahid Beheshti University of Medical Sciences, Tehran , Dabbagh, Ali Anesthesiology Research Center - Shahid Beheshti University of Medical Sciences, Tehran , Mosaffa, Faramarz Anesthesiology Research Center - Shahid Beheshti University of Medical Sciences, Tehran , Dabir, Shideh Anesthesiology Research Center - Shahid Beheshti University of Medical Sciences, Tehran , Moshari, Mohammadreza Anesthesiology Research Center - Shahid Beheshti University of Medical Sciences, Tehran , Seyed Alshohadaei, Mohammad Anesthesiology Research Center - Shahid Beheshti University of Medical Sciences, Tehran , Baghizadeh, Fereshteh Anesthesiology Research Center - Shahid Beheshti University of Medical Sciences, Tehran
Abstract :
Background: Neurotoxicity effects of anesthetics in different age groups is a
major concern regarding neural injuries. It is reasonable to recognize the
neurotoxicity risks of anesthetic drugs and their combinations.
Materials and Methods: A total of 16 mice (Mus musculus) weighing 22 to
30 gr were randomly divided into four drug groups (control, Ropivacaine,
Ropivacaine + Dexmedetomidine, Ropivacaine + Dexamethasone). 24 hours
after unilateral injection of drugs into the femoral nerve of mice, the mice were
killed and their femoral nerve was removed. Hematoxylin-eosin tissue staining
was used to evaluate changes in the effects of the drugs, and nerve samples
were extracted to measure TLR4 and caspase 3 expressions. After Western
blotting, the protein expression level was checked between different groups.
Results: Ropivacaine in combination with dexamethasone caused less damage
to the rat nerve cells. The combination of ropivacaine with dexamethasone
(p=0.53 and p=0.46) compared to the combination of ropivacaine with
dexmedetomidine relatively had better results in terms of cytotoxicity.
Conclusion: A combination of ropivacaine with dexamethasone reduces
neurotoxicity risk.
Keywords :
Ropivacaine , Dexmedetomidine , Dexamethasone , Toll-like receptors , Glyceraldehyde 3-phosphate dehydrogenase , Cysteine-aspartic acid protease